Title: Unit 11 Quiz
Course: SAT 170 Introductory Biotechnology > Section: SAT 170 Introductory Biotechnology

Q: Which of the following is true regarding allele-specific oligonucleotide (ASO) analysis?
- it uses short synthetic fragments of DNA
- it examines specific sequences of DNA
- it can be used to identify specific single nucleotide polymorphisms (SNPs)
- it is more specific than restriction fragment length polymorphism (RFLP) analysis
- all of the above
A: all of the above

Q: Which of the following correctly defines the term karyotype?
- is a group or cluster of single nucleotide polymorphisms (SNPs) on a particular chromosome
- a substance produced by immune cells in response to the presence of an antigen to protect the body against that antigen
- a substance which can elicit an immune response and the production of antibodies
- it is the shape, appearance and number of chromosomes in an individual’s cells
- a form of prenatal testing where fetal cells are collected for examination of genetic content
A: it is the shape, appearance and number of chromosomes in an individual’s cells

Q: Which of the following correctly describes a hybridoma?
- a cell which results from the fusion of a specific antibody producing cell with a myeloma cell
- a cancerous plasma cell
- a patient that has received a transplant through xenotransplantation
- a genetically engineered organism which has had one or more genes inactivated
- none of the above
A: a cell which results from the fusion of a specific antibody producing cell with a myeloma cell

Q: Which of the following correctly describes a biomarker?
- a measurable characteristic that is used as an indicator of a biological process
- a measurable differences in the number and type of restriction sites within different DNA samples
- a single nucleotide variation that exists within different DNA samples
- a similar structure found in different species; often refers to an organ, structure or even a gene
- a group or cluster of SNPs on a particular chromosome
A: a measurable characteristic that is used as an indicator of a biological process

Q: Which of the following is true regarding regenerative medicine?
- it is a form of immunotherapy
- it uses biopharmaceuticals
- it relies on biodiasgnostics
- it uses stem cells and tissue engineering
- all of the above
A: it uses stem cells and tissue engineering

Q: Pharmacogenomics is a field which studies medical drugs that are produced using biotechnology.
- True
- False
A: False

Q: Biodiagnostics is a field which focuses on the identification of biomarkers or gene variants to detect diseases and disorders.
- True
- False
A: True

Q: Protein therapy has successfully been used for the treatment of diabetes and dwarfism in humans.
- True
- False
A: True

Q: A(n) ___________________________ is a group or cluster of single nucleotide polymorphisms (SNPs) on a particular chromosome.

Q: ___________________________ gene therapy involves first removing cells from the patient and then introducing the healthy gene into these cells before the cells are placed back into the patient.

Q: ___________________________ organisms are those which have had at least one gene inactivated or silenced.

Q: A(n)___________________________ is a substance produced by immune cells in response to the presence of an antigen to protect the body against that antigen.

Q: Describe two ways in which model organisms can be used in the field of medicine.

Q: What are nanoparticles? How can they be used as a drug delivery system?